The prospect of reversing type 2 diabetes through strategic dietary intervention represents one of the most significant developments in metabolic medicine, potentially freeing millions from lifelong medication dependence and progressive complications. This systematic comparison of two leading nutritional approaches could help clinicians determine which patients benefit most from Mediterranean versus low-carbohydrate protocols for achieving sustained diabetes remission.
The Lebanese trial will randomize 50 adults with diabetes duration under six years to follow either a calorie-restricted Mediterranean diet or a low-calorie, low-carbohydrate regimen. Both groups undergo six months of intensive dietary intervention using behavioral mapping protocols, followed by six months of mobile app-supported maintenance. The primary endpoint measures diabetes remission at six months, defined as hemoglobin A1c below 6.5 percent with possible medication discontinuation, while tracking sustained remission through the full twelve-month period.
This head-to-head comparison fills a critical gap in diabetes reversal research, where most studies examine single dietary approaches rather than direct comparisons of competing methodologies. The Mediterranean approach emphasizes whole grains, legumes, and healthy fats, while low-carbohydrate protocols typically restrict total carbohydrate intake below 130 grams daily. Both strategies have demonstrated metabolic benefits in isolation, but their relative effectiveness for diabetes remission remains unclear.
The study's limitation to recently diagnosed patients within six years suggests optimal intervention timing, when beta-cell function may retain greater reversibility. However, the modest sample size and single-region focus may limit generalizability across diverse populations and healthcare systems, requiring larger multicenter validation before widespread clinical implementation.